Related Experiment Video
Updated: Oct 31, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors
Lin Xiao1, Harrison Yeung2, Michelle Haber1
1Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales Sydney, NSW 2052, Australia; School of Women's and Children's Health, University of New South Wales Sydney, Randwick, NSW 2052, Australia.
Abstract:
Despite the success of immunotherapies in adult solid cancers and pediatric hematological malignancies, limited progress has been made towards implementing these strategies in pediatric solid tumors. These tumors exhibit a high potential to escape antitumor immunity, making them difficult to target by current immunotherapies. This review highlights the altered metabolic pathways in pediatric solid tumors that promote immune escape, and discusses current novel strategies targeting these pathways. We further explore how these strategies could be applied to potentiate immunotherapies for pediatric solid cancers and pose key questions yet to be addressed. Translational challenges to facilitate clinical application of antimetabolic strategies through personalized medicine are identified. We propose preclinical testing of antimetabolic approaches in combination with immunotherapies for pediatric solid cancers.
Insights
Pediatric solid tumors evade immune attack, hindering immunotherapy. Targeting tumor metabolism offers a novel strategy to enhance immunotherapy effectiveness in children with solid cancers.
Area of Science:
- Oncology
- Immunology
- Metabolic pathways
Background:
- Immunotherapies show success in adult cancers and pediatric blood cancers, but not pediatric solid tumors.
- Pediatric solid tumors possess mechanisms to evade the immune system, limiting current immunotherapy efficacy.
- Altered tumor metabolism is a key factor in immune evasion within pediatric solid tumors.
Purpose of the Study:
- To review metabolic alterations in pediatric solid tumors that promote immune escape.
- To discuss novel strategies targeting these metabolic pathways.
- To explore the potential of combining metabolic targeting with immunotherapy for pediatric solid cancers.
Main Methods:
- Literature review of metabolic pathways in pediatric solid tumors.
- Analysis of current antimetabolic strategies.
- Exploration of potential therapeutic combinations and translational challenges.
Main Results:
- Pediatric solid tumors exhibit specific metabolic reprogramming that supports immune evasion.
- Targeting these metabolic pathways presents a promising avenue for overcoming immunotherapy resistance.
- Combination of antimetabolic strategies with immunotherapies could enhance treatment efficacy.
Conclusions:
- Metabolic reprogramming in pediatric solid tumors is a critical target for improving immunotherapy outcomes.
- Novel antimetabolic strategies hold potential for potentiating immunotherapies in pediatric solid cancers.
- Further research and preclinical testing are needed to translate these findings into clinical applications, particularly through personalized medicine approaches.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Tumor Immunotherapy
Regulation of Metabolism

